Global Information
회사소개 | 문의 | 비교리스트

탈회화 골기질(DBM) 시장 : 성장, 동향, 예측(2020-2025년)

Demineralized Bone Matrix Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

리서치사 Mordor Intelligence Pvt Ltd
발행일 2022년 01월 상품코드 927852
페이지 정보 영문 배송안내 2-3일 (영업일 기준)
US $ 4,750 ₩ 6,176,000 PDF (Single User License)
US $ 5,250 ₩ 6,827,000 PDF (Team License: Up to 7 Users)
US $ 6,500 ₩ 8,452,000 PDF (Site License)
US $ 8,750 ₩ 11,378,000 PDF (Corporate License)

탈회화 골기질(DBM) 시장 : 성장, 동향, 예측(2020-2025년) Demineralized Bone Matrix Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
발행일 : 2022년 01월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 탈회화 골기질(DBM) 시장은 예측기간 동안 약 5.5%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다. 정형외과 질환 발생률 상승, 척추 고정술 및 치과 수술 증가, 인구 증가에 따른 환자 증가가 예측기간 동안 시장을 성장을 견인하는 요인입니다. 탈회화 골기질(DBM)은 뼈/ 관절 장애 등 많은 용도의 정형외과에서 널리 사용되고 있습니다. 뼈가 약해지면서 발생하는 정형외과 질환 증가 사례가 수요를 가속화할 것으로 예측됩니다. 세계 보건기구의 인구 부문에 따르면, 60세 이상 인구는 2015년 9억 명에 달했고, 2050년에는 20억 명에 이를 것으로 예측됩니다. 따라서 정형외과 질환이 발병하기 쉬운 노년 인구가 증가함에 따라 세계 탈회화 골기질 시장은 성장할 것으로 예상되며, 예측기간 동안 수요는 급증할 것으로 예상됩니다.

골유도성과 골전도성 등 탈회화 골기질(DBM)의 합병증 발생률이 크게 낮은 장점이 시장의 길을 열어줄 것입니다.

또한 천연 뼈조직의 필수 생화학적 조성, 아키텍처, surface topography를 유지하는 탈염 뼈 기질을 이용한 생체 모방/이식 가능 마이크로캐리어 형성과 같은 기술 발전은 최근 업계 성장에 있어서 중요한 역할을 했습니다. 재료 설계 및 동종 이식 기술 진보 뿐만 아니라, 다양한 복잡한 수술에 사용되기 때문에 이것들은 중요한 개발로 간주하고 있습니다. 그러나 탈회화 골기질(DBM)의 높은 비용은 시장을 방해할 수 있습니다.

세계의 탈회화 골기질(DBM: Demineralized Bone Matrix) 시장에 대해 조사했으며, 시장 기회 및 동향, 성장 촉진요인 및 억제요인, 부문별/지역별 시장 분석, 경쟁 상황, 주요 기업 개요 등의 정보를 전해드립니다.


제1장 서론

  • 조사의 전제조건
  • 조사 범위

제2장 조사 방법

제3장 개요

제4장 시장 역학

  • 시장 개요
  • 시장 성장 촉진요인
    • 정형외과 질환 발생률 상승
    • 척추 고정술 및 치과 수술 증가
    • 인구 증가에 따른 환자 증가
  • 시장 성장 억제요인
    • 탈회화 골기질(DBM)의 높은 비용
  • Porter's Five Forces 분석
    • 신규 진출기업의 위협
    • 구매자/소비자의 교섭력
    • 공급업체의 협상력
    • 대체품의 위협
    • 업계 내 경쟁

제5장 시장 세분화

  • 제품 유형별
    • Gel
    • Putty
    • Putty with Chips
    • 기타
  • 용도별
    • 치과
    • 두개악안면
    • Joint Reconstruction
    • Long Bone
    • 척추 융합
    • 기타
  • 지역별
    • 북미
    • 유럽
    • 아시아태평양
    • 중동 및 아프리카
    • 남미

제6장 경쟁 상황

  • 기업 개요
    • Hans Biomed
    • Institut Straumann Ag
    • J&J(Depuy Synthes)
    • Medtronic
    • RTI Surgical Holdings, Inc
    • Seaspine
    • Stryker
    • Wright Medical Group NV
    • Xtant Medical
    • Zimmer Biomet

제7장 시장 기회 및 향후 동향

LSH 20.05.28

The global demineralized bone matrix market studied was anticipated to grow with a CAGR of nearly 5.5% during the forecast period. Rising incidence of orthopedic disorders, increasing number of spinal fusion and dental surgeries, increasing patient base with growing population are the factors expected to drive the market during the forecast period. Demineralized bone matrix is widely used in orthopedic surgeries for numerous applications such as bone & joint disorders. Rising cases of orthopedic disorders caused due to weakened bones are projected to fuel demand. According to the world Health Organization, Population Division, the number of people aged over 60 was 900 million in 2015 and is expected to reach 2 billion in 2050. Thus, the number of orthopedic disorders is expected to grow with rising geriatric population prone to orthopedic ailments. Thus, the market is anticipated to witness significant demand during the forecast period.

The benefits provided by demineralized bone matrix such as osteoinductivity and osteoconductivity with a significantly lower complication rate pave a way for the market.

Furthermore, technological advancements such as formation of biomimetic and implantable microcarrier using demineralized bone matrix which preserves the essential biochemical composition, architecture and surface topography of natural bone tissue have played a principal role in industry growth during the recent years. Besides advancements in materials, designs, & allografting techniques are considered as a crucial development as they are used in various complex surgeries. However, high cost of demineralized bone matrix may hamper the market.

Key Market Trends

Spinal Fusion Segment Is Anticipated To Witness The Significant Growth Rate and is Expected to Continue to Do the Same during the Forecast Period

  • Spinal fusion segment is anticipated to witness the significant growth rate through the forecast period. Spinal fusion is used to correct defects in vertebrae of the spine. According to the European Spine Journal in 2017, De novo degenerative lumbar scoliosis is a spinal deformity in the elderly population that leads to disabiling LBP/leg pain and suboptimal quality of life. To curb this problem, demineralized bone matrix are being adopted as a treatment of choice for these spinal deformities.
  • Therefore increasing number of elderly population suffering from these spinal disorders and rising adoption of demineralized bone matrix procedure as a treatment method is anticipated to escalate the revenue for the segment over the forecast period.

North America Represents the Largest Market and Asia-Pacific is Expected to Register Fastest Growth.

North America captured the largest share in the global market. Awareness regarding the commercially available products, higher healthcare expenditure 17.7% in 2018, and availability of advanced healthcare infrastructure are the major factors contributing toward its growth. Government organizations such as North American Spine Foundation, initiated the campaign for awareness and educate healthcare professionals and public about treatment option that likely to drive growth. The U.S., in particular, is leading the global market by generating the maximum product demand on account of the high prevalence of orthopedic diseases and trauma-related injuries. These factors contribute to the segment's dominance throughout the forecast period.

Asia Pacific market is anticipated to witness the fastest growth over the forecast period. High level of population, developing economies, and increasing demand for advanced treatment options are factors anticipated to drive growth in the Asia Pacific region at the highest rate during the forecast period. In addition, favorable government policies such as China's healthcare reform and approval of 100 % foreign direct investment in medical devices sector by the Indian government have contributed to the growth of the market. These two countries along with Japan are expected to spearhead the growth of the regional market. For instance, the recent approval of Medtronic's grafton Demineralized Bone Matrix in Japan in 2019, the regional market is poised to register lucrative growth in this region over coming few years.

Competitive Landscape

The market is characterized by high competition based on price, product differentiation, and low cost of technology. It is also marked by increased focus on development of innovative products and a successful track record of mergers and acquisitions. Major manufacturers, raw material suppliers, and machinery manufacturers have been working in tandem to research, develop, and innovate new products within the field of allograft. Some of the key industry players are J &J (Depuy Synthes); Medtronic; Wright Medical Group N.V.; Zimmer Biomet and Stryker.

The entry of new players especially in market is expected to boost the market growth with huge untapped opportunities. In February 2019, Medtronic launched Grafton DBM in Japan, which was the first-ever DBM in this country. This initiative is expected to increase the company's regional penetration.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support



  • 1.1 Study Assumptions
  • 1.2 Scope of the Study




  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Incidence of Orthopedic Disorders
    • 4.2.2 Increasing Number of Spinal Fusion and Dental Surgeries
    • 4.2.3 Increasing Patient Base With Growing Population
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Demineralized Bone Matrix
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry


  • 5.1 By Product Type
    • 5.1.1 Gel
    • 5.1.2 Putty
    • 5.1.3 Putty with Chips
    • 5.1.4 Others
  • 5.2 By Application
    • 5.2.1 Dental
    • 5.2.2 Craniomaxillofacial
    • 5.2.3 Joint Reconstruction
    • 5.2.4 Long Bone
    • 5.2.5 Spinal Fusion
    • 5.2.6 Others
  • 5.3 Geography
    • 5.3.1 North America
      • United States
      • Canada
      • Mexico
    • 5.3.2 Europe
      • Germany
      • United Kingdom
      • France
      • Italy
      • Spain
      • Rest of Europe
    • 5.3.3 Asia-Pacific
      • China
      • Japan
      • India
      • Australia
      • South Korea
      • Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
      • GCC
      • South Africa
      • Rest of Middle-East and Africa
    • 5.3.5 South America
      • Brazil
      • Argentina
      • Rest of South America


  • 6.1 Company Profiles
    • 6.1.1 Hans Biomed
    • 6.1.2 Institut Straumann Ag
    • 6.1.3 J &J (Depuy Synthes)
    • 6.1.4 Medtronic
    • 6.1.5 RTI Surgical Holdings, Inc
    • 6.1.6 Seaspine
    • 6.1.7 Stryker
    • 6.1.8 Wright Medical Group N.V.
    • 6.1.9 Xtant Medical
    • 6.1.10 Zimmer Biomet


Back to Top
전화 문의